Table 1 Characteristics of recruited patients with and without adenomyosis
From: Possible involvement of neuropeptide and neurotransmitter receptors in Adenomyosis
Variable name | Control (n = 24) | Adenomyosis (n = 30) | p-value |
|---|---|---|---|
Age | |||
Mean (±S.D.) | 41.3 ± 4.1 | 40.0 ± 2.2 | 0.13 |
Median (range) | 42 (31—47) | 40 (34—43) | |
Parity | |||
0 | 0 (0.0%) | 4 (13.3%) | 0.23 |
1 | 14 (58.3%) | 16 (53.3%) | |
≥ 2 | 10 (41.7%) | 10 (33.3%) | |
Menstrual phase | |||
Proliferative | 14 (58.3%) | 16 (53.3%) | 0.79 |
Secretory | 10 (41.7%) | 14 (46.7%) | |
Amount of menses | |||
Light | 0 (0.0%) | 1 (3.3%) | 1.4 × 10−5 |
Moderate | 24 (100.0%) | 14 (46.7%) | |
Heavy | 0 (0.0%) | 15 (50.0%) | |
Severity of dysmenorrhea | |||
None | 22 (91.6%) | 3 (10.0%) | 4.8 × 10−10 |
Mild | 1 (4.2%) | 3 (10.0%) | |
Moderate | 1 (4.2%) | 6 (20.0%) | |
Severe | 0 (0.0%) | 18 (60.0%) | |
Ovarian endometrioma | |||
Absent | 24 (100.0%) | 28 (93.3%) | 0.50 |
Present | 0 (0.0%) | 2 (6.7%) | |
Deep endometriosis | |||
Absent | 24 (100.0%) | 25 (83.3%) | 0.059 |
Present | 0 (0.0%) | 5 (16.7%) | |
Uterine fibroids | |||
Absent | 24 (100.0%) | 21 (70.0%) | 0.0029 |
Present | 0 (0.0%) | 9 (30.0%) | |
Uterine size (in cm3) | |||
Mean (±S.D.) | 63.3 ± 21.0 | 304.8 ± 103.8 | 1.4 × 10−15 |
Median (range) | 63.3 (33.0—116.8) | 295.9 (130.3—531.1) | |